Carlson Capital’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-875,000
| Closed | -$604K | – | 225 |
|
|
2020
Q4 | $604K | Sell |
875,000
-293,896
| -25% | -$203K | 0.02% | 145 |
|
|
2020
Q3 | $2.63M | Buy |
1,168,896
+243,896
| +26% | +$549K | 0.08% | 157 |
|
|
2020
Q2 | $3.31M | Buy |
925,000
+490,000
| +113% | +$1.75M | 0.09% | 142 |
|
|
2020
Q1 | $1.65M | Buy |
435,000
+159,112
| +58% | +$605K | 0.04% | 163 |
|
|
2019
Q4 | $830K | Buy |
+275,888
| New | +$830K | 0.02% | 217 |
|